Open AccessCharacterization ofbftGenes among EnterotoxigenicBacteroides fragilisIsolates from Extraintestinal Specimens at a University Hospital in Korea
Author(s) -
MyungSook Kim,
Hyunsoo Kim,
Seung Eun Ji,
John Hoon Rim,
Sun-Yeong Gwon,
Wan Hee Kim,
KiJong Rhee,
Kyungwon Lee
Publication year - 2016
Publication title -
korean journal of clinical laboratory science
Language(s) - Uncategorized
Resource type - Journals
eISSN - 2288-1662
pISSN - 1738-3544
DOI - 10.15324/kjcls.2016.48.2.82
Subject(s) - bacteroides fragilis , cefoxitin , microbiology and biotechnology , piperacillin , clindamycin , imipenem , biology , antibiotics , bacteria , antibiotic resistance , genetics , staphylococcus aureus , pseudomonas aeruginosa
Enterotoxigenic Bacteroides fragilis (ETBF) . B. fragilis enterotoxin (BFT) bft- 1, bft- 2 bft- 3 . B. fragilis bft BFT . 8(2006∼2013) B. fragilis 537. bft . BFT 74 33 B. fragilis 107 CLSI . B. fragilis bft 30% , 33%, 29% . ETBF bft- 1 , bft- 2, bft- 3 ( bft- 1: 77%, bft- 2: 14%, bft- 3: 9%). BFT- (BFT- : piperacillin-tazobactam 3%, cefoxitin 5%, imipenem 1%, clindamycin 38%; BFT- : piperacillin-tazobactam 3%, cefoxitin 6%, imipenem 3%, clindamycin 42%). BFT- BFT- chloramphenicol metronidazole . , ETBF , bft- 1 . BFT .
Accelerating Research
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom
Address
John Eccles HouseRobert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom